Interview: “Oncology Trials are Different”

 

“Oncology trials are different” states Dr Johann Proeve, our Chief Scientific Officer, in his latest video interview about “one-size doesn’t fit all” when it comes to risk management. Many risks in clinical trials seem therapy specific. To illustrate this, Johann shares real life use cases he experienced during his years as Head of Global Data Management at Bayer HealthCare.

Take a peek: Interview – Oncology Trials are Different

See also: Oncology Risk Assessment and Categorization Tool (OncoRACT)

By |2018-10-02T05:41:24+00:00May 3, 2018|Blog, News|Comments Off on Interview: “Oncology Trials are Different”
Linda has 25+ years of experience uncovering pain points and strategizing with companies in the healthcare industry in order to secure and retain more clients. Her chief thinking responsibilities include translating insight into strategy and ensure that all MarCom and Product Management activities contribute to our overall customer experience and meet our industry’s quality expectations.

Upcoming Events

  1. DIA Europe 2019

    February 5 - February 7

Register Today!

Get Free Test Access